Dr. John D. Kisiday, Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Zeo ScientifiX, Inc. publishes a filing, an earnings call transcript or a press release.
Get ZEOX alertsAbout Dr. John D. Kisiday, Ph.D.
Zeo ScientifiX, Inc. reported in an 8-K filed January 28, 2026 that Dr. John D. Kisiday, Ph.D. was appointed Chief Science Officer, effective January 23, 2026. Zeo ScientifiX, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zeo ScientifiX, Inc. includes Harry Leider (CEO), Harry Leider, M.D., M.B.A. (CEO and Board Member), Ian Bothwell (CEO and Board Member) and 7 others.
“Effective January 23, 2026, Dr. John D. Kisiday, Ph.D. (“Dr. Kisiday”) was appointed the Company’s Chief Science Officer.”
Affiliation history
-
Zeo ScientifiX, Inc. (ZEOX)
SEC 8-K
Current2026-01-23–present
Company network
Leadership on record at Zeo ScientifiX, Inc.
- Harry Leider CEO
- Harry Leider, M.D., M.B.A. CEO, Board Member
- Ian Bothwell CEO, Board Member
- Ian T. Bothwell CEO
- Matthew Sinnreich CEO, COO, Board Member
- Bhupendra Kumar Modi Chairman, Board Member
- Dr. Bhupendra Kumar Modi Chairman, Board Member
- Dr. Modi Chairman
- Ryan Likes COO
- Chuck Bretz Board Member